Evidence map›Paper›PMID 20506303›Full record

ArticleStem cells (Dayton, Ohio)2010

Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1.

Kalindi Parmar, Jungmin Kim, Stephen M Sykes, Akiko Shimamura, Patricia Stuckert, Kaya Zhu, Abigail Hamilton, Mary Kathryn Deloach, Jeffery L Kutok, Koichi Akashi and 2 more

Abstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. DNA damage and repair in the hematopoietic system.Acta biochimica et biophysica Sinica · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. DNA repair fidelity in stem cell maintenance, health, and disease.Biochimica et biophysica acta. Molecular basis of disease · 2020
    Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kalindi ParmarDepartment of Radiation Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Jungmin Kim
Stephen M Sykes
Akiko Shimamura
Patricia Stuckert
Kaya Zhu
Abigail Hamilton
Mary Kathryn Deloach
Jeffery L Kutok
Koichi Akashi
D Gary Gilliland
Alan D'andrea

Funding

Genetic screens for IR resistanceU19AI067751 · NIAID · DANA-FARBER CANCER INSTITUTE · PI D'ANDREA, ALAN D. · 2005 to 2009
$9.9M
MOLECULAR PATHOGENESIS OF FANCONI ANEMIAR01HL052725 · NHLBI · DANA-FARBER CANCER INSTITUTE · PI ALAN D. D'ANDREA · 1994 to 2026
$5.9M
STRUCTURE AND FUNCTION OF THE ERYTHROPOIETIN RECEPTORR01DK043889 · NIDDK · DANA-FARBER CANCER INSTITUTE · PI D'ANDREA, ALAN D. · 1992 to 2014
$5.3M
Molecular Pathogenesis of Fanconi AnemiaR37HL052725 · NHLBI · DANA-FARBER CANCER INSTITUTE · PI D'ANDREA, ALAN D. · 2004 to 2013
$3.9M
Shwachman-Diamond Syndrome: Molecular PathogenesisR01HL079582 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SHIMAMURA, AKIKO · 2004 to 2012
$3.7M
NHLBI NIH HHS R01 HL052725NHLBI NIH HHS R01 HL079582NHLBI NIH HHS R01HL52725NHLBI NIH HHS R37 HL052725NIAID NIH HHS U19 AI067751NIDDK NIH HHS R01 DK043889NIDDK NIH HHS R01DK43889PHS HHS U19A1067751
6 · The paper itself

Abstract

Fanconi anemia (FA) is a human genetic disease characterized by a DNA repair defect and progressive bone marrow failure. Central events in the FA pathway are the monoubiquitination of the Fancd2 protein and the removal of ubiquitin by the deubiquitinating enzyme, Usp1. Here, we have investigated the role of Fancd2 and Usp1 in the maintenance and function of murine hematopoietic stem cells (HSCs). Bone marrow from Fancd2-/- mice and Usp1-/- mice exhibited marked hematopoietic defects. A decreased frequency of the HSC populations including Lin-Sca-1+Kit+ cells and cells enriched for dormant HSCs expressing signaling lymphocyte activation molecule (SLAM) markers, was observed in the bone marrow of Fancd2-deficient mice. In addition, bone marrow from Fancd2-/- mice contained significantly reduced frequencies of late-developing cobblestone area-forming cell activity in vitro compared to the bone marrow from wild-type mice. Furthermore, Fancd2-deficient and Usp1-deficient bone marrow had defective long-term in vivo repopulating ability. Collectively, our data reveal novel functions of Fancd2 and Usp1 in maintaining the bone marrow HSC compartment and suggest that FA pathway disruption may account for bone marrow failure in FA patients.

Indexed as

AnimalsArabidopsis ProteinsBone MarrowCell LineCell SurvivalEndopeptidasesFanconi AnemiaFanconi Anemia Complementation Group D2 ProteinHematopoietic Stem CellsMiceMice, Inbred C57BLOrgan SpecificityUbiquitin-Specific ProteasesArabidopsis ProteinsEndopeptidasesFancd2 protein, mouseFanconi Anemia Complementation Group D2 ProteinUbiquitin-Specific ProteasesUSP1 protein, humanUsp1 protein, mouse

Identifiers

PMID20506303
PMCPMC2910804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.